Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genetically Modified Stem Cells are Effective Against Acute Respiratory Diseases

Published: Tuesday, June 18, 2013
Last Updated: Tuesday, June 18, 2013
Bookmark and Share
Administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury.

Study results were published in the American Journal of Respiratory Cell and Molecular Biology.

Acute lung injury

Acute lung injury and its more severe manifestation, the acute respiratory distress syndrome, are characterized by very severe inflammatory processes that damage the lungs with a mortality of between 40% and 50%. Currently there is no effective treatment beyond palliative care and mechanical assistance to breath.

"In the last years we have been working in the administration of human mesenchymal stem cells from adipose tissue obtained from liposuction in different pathologies," said the researcher of Human Molecular Genetics reserach group at IDIBELL Josep Maria Aran. "We have found that these stem cells are able to easily reach the lungs and there, secrete anti-inflammatory substances and growth factors."

Alarm signal

The studies conducted so far with these cells have shown a positive effect. IDIBELL and VHIR researchers have introduced a genetic modification in these cells that improves treatment.

The cytokine IL33 is a protein that acts as an alarm signal in these patients. When the damage into the lungs begins, the cells secrete this highly proinflammatory substance and elicit a very strong immune system answer.

"We believed," says Aran, "that if we modified genetically mesenchymal stem cells to secrete a molecule antagonist of IL-33, we could stop the inflammatory process and we found that, in mice, the effect was more positive than unmodified cells: regeneration of lung tissue and practically nullifies the inflammatory process in the lungs. "

IDIBELL has signed a licensing agreement with the Basque company Histocell for this genetic modification and currently they are working to make this "smart drug" may reach the clinical stage and try to patients.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

IDIBELL and VHIR licenses Histocell a Patent for Acute Respiratory Diseases with Stem Cells
It is a "smart drug" that can reduce inflammation and regenerate damaged tissue.
Tuesday, April 09, 2013
IDIBELL Licenses Histocell a Patent for Acute Respiratory Diseases with Stem Cells
It is a "smart drug" that can reduce inflammation and regenerate damaged tissue.
Wednesday, April 03, 2013
IDIBELL licenses Histocell a Patent for Acute Respiratory Diseases with Stem Cells
It is a "smart drug" that can reduce inflammation and regenerate damaged tissue.
Wednesday, March 27, 2013
Scientific News
Human Stem Cells to Rapidly Generate Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Rapid Generation from Stem Cells
Researchers coax human stem cells to rapidly generate bone and heart muscle by directing stem cells down complex developmental pathways.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!